Not available
Quote | ARCA biopharma Inc. (NASDAQ:ABIO)
Last: | $3.48 |
---|---|
Change Percent: | -0.28% |
Open: | $3.64 |
Close: | $3.48 |
High: | $3.6585 |
Low: | $3.4101 |
Volume: | 53,994 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | ARCA biopharma Inc. (NASDAQ:ABIO)
2024-04-25 17:17:28 ET More on ARCA biopharma ARCA biopharma to merge with Oruka Therapeutics in all-stock transaction Financial information for ARCA biopharma Read the full article on Seeking Alpha For further details see: ARCA biopharma GAAP EPS of -$0.14
ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company app...
Message Board Posts | ARCA biopharma Inc. (NASDAQ:ABIO)
Subject | By | Source | When |
---|---|---|---|
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing | INFINITI | investorshub | 10/29/2021 11:35:26 AM |
ARCA biopharma shares surge 30% on positive DSMC | INFINITI | investorshub | 10/29/2021 11:33:58 AM |
Looks good got some $$$ | INFINITI | investorshub | 10/29/2021 11:33:20 AM |
whytestocks: $ABIO News Article - ARCA biopharma to Present at Access to Giving Virtual Investor Con | whytestocks | investorshangout | 07/09/2021 3:51:00 PM |
whytestocks: $ABIO News Article - ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreeme | whytestocks | investorshangout | 07/07/2021 5:57:41 PM |
News, Short Squeeze, Breakout and More Instantly...
ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25,...
ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company app...
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...